Clinical Trial

Pleuroscopy First Versus Thoracentesis First in Patients With Suspected Malignant Pleural Effusions

Study acronym: PERFECT-MPE
Recruiting
View on ClinicalTrials.gov →
Summary
This is a randomized control trial of patients with suspected malignant pleural effusions to compare whether patients who have a thoracentesis or pleuroscopy (pleural biopsy) obtain an adequate biopsy, achieve a diagnosis, and begin cancer-directed therapy faster.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-19.
Trial Details
NCT Number NCT06892691
Lead Sponsor Icahn School of Medicine at Mount Sinai
Conditions Pleural Effusion, Cancer
Enrollment 98 participants
Start Date 2025-03-24
Primary Completion 2026-09-17 (estimated)
Study Completion 2026-09-17 (estimated)
Updated on ClinicalTrials.gov 2026-02-04